Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide

H. Lee Moffitt Cancer Center and Research Institute · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
multiple-myeloma
multiple myeloma, lenalidomide maintenance, hematopoietic cell transplantation, serologic relapse, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 810245
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.